- Home
- BCYC vs PEO Comparison
BCYC vs PEO Comparison
Compare BCYC & PEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- PEO
- Stock Information
- Founded
- BCYC 2009
- PEO 1929
- Country
- BCYC United Kingdom
- PEO United States
- Employees
- BCYC N/A
- PEO N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- PEO Finance/Investors Services
- Sector
- BCYC Health Care
- PEO Finance
- Exchange
- BCYC Nasdaq
- PEO Nasdaq
- Market Cap
- BCYC 492.1M
- PEO 577.0M
- IPO Year
- BCYC 2019
- PEO N/A
- Fundamental
- Price
- BCYC $6.92
- PEO $21.73
- Analyst Decision
- BCYC Buy
- PEO
- Analyst Count
- BCYC 11
- PEO 0
- Target Price
- BCYC $22.91
- PEO N/A
- AVG Volume (30 Days)
- BCYC 213.9K
- PEO 35.4K
- Earning Date
- BCYC 10-30-2025
- PEO 01-01-0001
- Dividend Yield
- BCYC N/A
- PEO 5.93%
- EPS Growth
- BCYC N/A
- PEO N/A
- EPS
- BCYC N/A
- PEO N/A
- Revenue
- BCYC $19,281,000.00
- PEO N/A
- Revenue This Year
- BCYC N/A
- PEO N/A
- Revenue Next Year
- BCYC N/A
- PEO N/A
- P/E Ratio
- BCYC N/A
- PEO N/A
- Revenue Growth
- BCYC N/A
- PEO N/A
- 52 Week Low
- BCYC $6.10
- PEO $19.22
- 52 Week High
- BCYC $28.67
- PEO $23.80
- Technical
- Relative Strength Index (RSI)
- BCYC 41.28
- PEO 56.25
- Support Level
- BCYC $6.77
- PEO $21.43
- Resistance Level
- BCYC $7.32
- PEO $21.78
- Average True Range (ATR)
- BCYC 0.39
- PEO 0.27
- MACD
- BCYC 0.01
- PEO 0.00
- Stochastic Oscillator
- BCYC 19.04
- PEO 53.13
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About PEO Adams Natural Resources Fund Inc.
Adams Natural Resources Fund Inc is a non-diversified U.S. equity fund that invests in liquid energy and other natural resources stocks. The Fund's investment objectives are preservation of capital, reasonable income, and opportunity for capital gain. A majority of its assets are invested in petroleum or natural resources industries or industries connected to them. It has broad flexibility to invest in stocks of varying capitalizations and predominantly invests in stocks found in the S&P 500 Energy and S&P 500 Materials sectors.